Journal of the American Academy of Dermatology
Volume 63, Issue 3 , Pages 457-465 , September 2010

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial

Limited portions of these data were presented at the 13th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Toronto, Ontario, Canada, May 3-7, 2008, and the Fifth International Congress on Psoriasis: From Gene to Clinic, London, United Kingdom, December 4-6, 2008.

  • Richard G. Langley, MD

      Affiliations

    • Dalhousie University, Halifax, Nova Scotia, Canada
    • ,
  • Steven R. Feldman, MD

      Affiliations

    • Wake Forest University School of Medicine, Winston-Salem, North Carolina
    • ,
  • Chenglong Han, PhD

      Affiliations

    • Worldwide Health Economics, Johnson & Johnson Pharmaceutical Services LLC, Horsham, Pennsylvania
    • ,
  • Brad Schenkel, MS

      Affiliations

    • Worldwide Health Economics, Johnson & Johnson Pharmaceutical Services LLC, Horsham, Pennsylvania
    • ,
  • Philippe Szapary, MD, MSCE

      Affiliations

    • Centocor, Inc, Malvern, Pennsylvania
    • ,
  • Ming-Chun Hsu, PhD

      Affiliations

    • Centocor, Inc, Malvern, Pennsylvania
    • ,
  • Jean-Paul Ortonne, MD

      Affiliations

    • Hôpital L'Archet, Nice, France
    • ,
  • Kenneth B. Gordon, MD

      Affiliations

    • Northwestern University Feinberg School of Medicine and Evanston Northwestern Healthcare, Chicago, Illinois
    • ,
  • Alexa B. Kimball, MD, MPH

      Affiliations

    • Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationReprint requests: Alexa B. Kimball, MD, MPH, Department of Dermatology, Harvard Medical School, 50 Staniford St, #246, Boston, MA 02114.

,Accepted 15 September 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by Centocor, Inc.

 Disclosures can be found in the Appendix.

PII: S0190-9622(09)01197-9

doi: 10.1016/j.jaad.2009.09.014

Journal of the American Academy of Dermatology
Volume 63, Issue 3 , Pages 457-465 , September 2010

Article Tools

* Image Usage & Resolution